|
KLHL12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6290000015573E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60130000004255E-06 |
| Normal-vs-Stage2 |
2.139600E-02 |
| Normal-vs-Stage3 |
3.7195999613715E-09 |
| Normal-vs-Stage4 |
2.62410000395619E-08 |
| Stage1-vs-Stage2 |
1.849440E-01 |
| Stage1-vs-Stage3 |
2.087900E-02 |
| Stage1-vs-Stage4 |
7.257600E-02 |
| Stage2-vs-Stage3 |
6.820500E-03 |
| Stage2-vs-Stage4 |
1.973940E-02 |
| Stage3-vs-Stage4 |
8.069400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.17259999488084E-08 |
| Normal-vs-AfricanAmerican |
5.817200E-04 |
| Normal-vs-Asian |
4.838600E-01 |
| Caucasian-vs-AfricanAmerican |
4.784000E-01 |
| Caucasian-vs-Asian |
1.901220E-01 |
| AfricanAmerican-vs-Asian |
3.270200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66259994660578E-09 |
| Normal-vs-Female |
4.35469999999771E-05 |
| Male-vs-Female |
4.144300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.31029999999888E-05 |
| Normal-vs-Age(41-60Yrs) |
1.71269999960089E-07 |
| Normal-vs-Age(61-80Yrs) |
2.95770000047213E-07 |
| Normal-vs-Age(81-100Yrs) |
4.137100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.165000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.904810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.935600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.630600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.822800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.254800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.843400E-01 |
| Normal-vs-Grade 2 |
2.55590000053374E-07 |
| Normal-vs-Grade 3 |
1.24619999986031E-07 |
| Normal-vs-Grade 4 |
9.72030000934154E-09 |
| Grade 1-vs-Grade 2 |
1.778610E-01 |
| Grade 1-vs-Grade 3 |
1.326760E-01 |
| Grade 1-vs-Grade 4 |
2.455600E-02 |
| Grade 2-vs-Grade 3 |
4.233200E-01 |
| Grade 2-vs-Grade 4 |
2.410300E-02 |
| Grade 3-vs-Grade 4 |
1.257190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.340890E-03 |
| Normal-vs-ccB subtype |
2.61970001247391E-09 |
| ccA subtype-vs-ccB subtype |
2.29019999999913E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.16909999994908E-06 |
| Normal-vs-N1 |
1.196820E-01 |
| N0-vs-N1 |
4.925000E-01 |
|
|
